 |
市場調査レポート
商品コード
1519340
神経刺激装置市場レポート：刺激タイプ、装置タイプ、用途、エンドユーザー、地域別、2024年～2032年Neurostimulation Devices Market Report by Stimulation Type, Device Type, Application, End-User, and Region 2024-2032 |
||||||
● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。 詳細はお問い合わせください。
| 神経刺激装置市場レポート：刺激タイプ、装置タイプ、用途、エンドユーザー、地域別、2024年～2032年 |
|
出版日: 2024年07月01日
発行: IMARC
ページ情報: 英文 143 Pages
納期: 2～3営業日
|
- 全表示
- 概要
- 図表
- 目次
世界の神経刺激装置市場規模は2023年に87億米ドルに達しました。今後、IMARC Groupは、2024年から2032年にかけて9.7%の成長率（CAGR）を示し、2032年までに206億米ドルに達すると予測しています。高齢化の進展とヘルスケア支出の増加、非侵襲性または低侵襲性の神経刺激技術の開拓、政府および民間医療保険者による償還政策の改善が、市場を推進する主な要因のひとつです。
神経刺激装置は、人体内の神経活動を調節し、影響を及ぼすように設計された高度な医療技術です。これらの機器は、神経系の特定部位に電気的または磁気的なインパルスを与えることで機能し、さまざまな神経症状や慢性疾患の緩和を目指します。非侵襲的あるいは低侵襲的な治療法として有望であり、患者の生活の質を高め、さまざまな神経疾患の治療に新たな道を開く可能性があります。神経刺激装置には、主に脳深部刺激と脊髄刺激の2種類があります。DBSは、標的とする脳部位に電極を埋め込み、異常な神経信号を調整し、パーキンソン病、本態性振戦、ジストニアなどの疾患を治療します。
高齢化人口の増加が世界市場を牽引しています。高齢者人口の増加に伴い、これらの症状を管理するための神経刺激装置の需要が高まる可能性が高いです。さらに、非侵襲性または低侵襲性の神経刺激技術が開発されたことで、潜在的な患者層が拡大しています。こうした選択肢は、従来の外科的処置に比べてリスクが軽減され、回復までの時間が短縮されることが多いからです。さらに、一部の地域では政府や民間の医療保険者による償還政策が改善されたことで、神経刺激治療が患者にとってより利用しやすくなり、市場の成長を促しています。また、現在進行中の調査や臨床試験により、神経刺激装置の安全性と有効性を示す新たな証拠が得られています。こうした研究による肯定的な結果は、医療関係者や患者の間でこの技術に対する信頼を高めています。さらに、神経刺激装置は慢性疾患の管理に費用対効果の高いアプローチを提供するため、医療費の増加が市場ソリューションの成長を支えており、これが普及の原動力となっています。
神経刺激装置市場傾向/促進要因：
神経疾患の有病率の増加
パーキンソン病、てんかん、慢性疼痛、うつ病などの神経疾患は、世界中で数百万人に影響を及ぼし、大きなヘルスケア負担につながっています。神経刺激装置は、従来の治療に抵抗性を示す患者や重篤な副作用を経験する患者に有望な解決策を提供します。脳深部刺激療法（DBS）は、パーキンソン病などの運動障害の治療において顕著な有効性を示しており、こうした機器の需要を高めています。さらに、特に高齢化と座りっぱなしの生活スタイルが原因で慢性疼痛の発生率が上昇しているため、薬に頼ることなく痛みを緩和する脊髄刺激（SCS）装置の必要性が高まっています。政府やヘルスケア機関が患者の転帰改善を優先し、革新的な解決策を模索する中、神経刺激装置の需要は着実に拡大すると予想されます。
神経刺激技術の絶え間ない進歩
継続的な研究開発努力により、より洗練された標的を絞った神経刺激装置が開発されています。革新的な技術には、より小型で精密な電極、バッテリー寿命の向上、患者のリアルタイムのニーズに基づいて刺激パラメーターを自動調整できる閉ループシステムの統合などがあります。これらの進歩は、治療成績の向上、副作用の軽減、患者の快適性の向上につながります。さらに、神経刺激装置を植え込むための低侵襲手術が開発されたことで、より幅広い患者層への適用が可能となり、患者とヘルスケア提供者の双方にとって治療がより身近で魅力的なものとなった。技術が進化し続けるにつれて、神経刺激装置はさらに効率的で適応性の高いものとなり、その普及と市場浸透をさらに後押しするものと思われます。
神経調節療法に対する認識と受容の高まり
さまざまな神経疾患の治療における神経刺激装置の有効性を裏付ける臨床的証拠が増えるにつれて、医療従事者がこれらの治療法を患者に勧めるケースが増えています。さらに、患者支援団体や啓発キャンペーンは、神経刺激の潜在的な利点について個人を啓蒙する上で重要な役割を果たし、こうした治療が患者に受け入れられるようになった。神経刺激装置によってQOLの大幅な改善を経験した患者のサクセスストーリーは、これらの治療法に対する好意的な認識をさらに助長しています。神経刺激療法に対する信頼が高まるにつれて、これらの機器に対する需要は増加し、市場の拡大に拍車がかかると予想されます。さらに、医療機関、研究者、機器メーカーが協力して認知度を広め、適切な使用を確保することが、神経刺激装置市場の持続的成長に寄与するであろう。
目次
第1章 序文
第2章 調査範囲と調査手法
- 調査の目的
- ステークホルダー
- データソース
- 一次情報
- 二次情報
- 市場推定
- ボトムアップアプローチ
- トップダウンアプローチ
- 調査手法
第3章 エグゼクティブサマリー
第4章 イントロダクション
- 概要
- 主要業界動向
第5章 世界の神経刺激装置市場
- 市場概要
- 市場実績
- COVID-19の影響
- 市場予測
第6章 市場内訳：刺激の種類別
- 内部刺激
- 市場動向
- 市場予測
- 外部刺激
- 市場動向
- 市場予測
第7章 市場内訳：装置タイプ別
- SCS（脊髄刺激）装置
- 市場動向
- 市場予測
- DBS（脳深部刺激）装置
- 市場動向
- 市場予測
- SNS（仙骨神経刺激）装置
- 市場動向
- 市場予測
- VNS（迷走神経刺激）装置
- 市場動向
- 市場予測
- GES（胃電気刺激）装置
- 市場動向
- 市場予測
- 経皮的電気神経刺激装置
- 市場動向
- 市場予測
- 経頭蓋磁気刺激装置
- 市場動向
- 市場予測
- その他
- 市場動向
- 市場予測
第8章 市場内訳：用途別
- 疼痛管理
- 市場動向
- 市場予測
- てんかん
- 市場動向
- 市場予測
- 本態性振戦
- 市場動向
- 市場予測
- 尿失禁および便失禁
- 市場動向
- 市場予測
- うつ
- 市場動向
- 市場予測
- ジストニア
- 市場動向
- 市場予測
- パーキンソン病
- 市場動向
- 市場予測
- その他
- 市場動向
- 市場予測
第9章 市場内訳：エンドユーザー別
- リハビリテーションセンター
- 市場動向
- 市場予測
- 病院
- 市場動向
- 市場予測
- 医療クリニック
- 市場動向
- 市場予測
- その他
- 市場動向
- 市場予測
第10章 市場内訳：地域別
- 北米
- 米国
- カナダ
- 欧州
- ドイツ
- フランス
- 英国
- イタリア
- スペイン
- ロシア
- その他
- アジア太平洋
- 中国
- 日本
- インド
- 韓国
- オーストラリア
- インドネシア
- その他
- ラテンアメリカ
- ブラジル
- メキシコ
- その他
- 中東・アフリカ
- 市場動向
- 市場内訳：国別
- 市場予測
第11章 SWOT分析
- 概要
- 強み
- 弱み
- 機会
- 脅威
第12章 バリューチェーン分析
- 概要
- インバウンド物流
- オペレーション
- 出荷物流
- マーケティングと販売
- アフターサービス
第13章 ポーターのファイブフォース分析
- 概要
- 買い手の交渉力
- 供給企業の交渉力
- 競合の程度
- 新規参入業者の脅威
- 代替品の脅威
第14章 価格指標
第15章 競合情勢
- 市場構造
- 主要企業
- 主要企業のプロファイル
- Biocontrol Medical
- Boston Scientific Corporation
- Cyberonics Inc.
- Medtronic Inc.
- Neuronetics Inc.
- Neuropace Inc.
- Neurosigma Inc.
- Nevro Corporation
- ST. Jude Medical Inc.
- Synapse Biomedical Inc.
List of Figures
- Figure 1: Global: Neurostimulation Devices Market: Major Drivers and Challenges
- Figure 2: Global: Neurostimulation Devices Market: Sales Value (in Billion US$), 2018-2023
- Figure 3: Global: Neurostimulation Devices Market: Breakup by Stimulation Type (in %), 2023
- Figure 4: Global: Neurostimulation Devices Market: Breakup by Device Type (in %), 2023
- Figure 5: Global: Neurostimulation Devices Market: Breakup by Application (in %), 2023
- Figure 6: Global: Neurostimulation Devices Market: Breakup by End-User (in %), 2023
- Figure 7: Global: Neurostimulation Devices Market: Breakup by Region (in %), 2023
- Figure 8: Global: Neurostimulation Devices Market Forecast: Sales Value (in Billion US$), 2024-2032
- Figure 9: Global: Neurostimulation Devices (Internal Stimulation) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 10: Global: Neurostimulation Devices (Internal Stimulation) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 11: Global: Neurostimulation Devices (External Stimulation) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 12: Global: Neurostimulation Devices (External Stimulation) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 13: Global: Neurostimulation Devices (Spinal Cord Stimulation Devices) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 14: Global: Neurostimulation Devices (Spinal Cord Stimulation Devices) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 15: Global: Neurostimulation Devices (Deep Brain Stimulation Devices) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 16: Global: Neurostimulation Devices (Deep Brain Stimulation Devices) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 17: Global: Neurostimulation Devices (Sacral Nerve Stimulation Devices) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 18: Global: Neurostimulation Devices (Sacral Nerve Stimulation Devices) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 19: Global: Neurostimulation Devices (Vagus Nerve Stimulation Devices) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 20: Global: Neurostimulation Devices (Vagus Nerve Stimulation Devices) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 21: Global: Neurostimulation Devices (Gastric Electrical Stimulation Devices) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 22: Global: Neurostimulation Devices (Gastric Electrical Stimulation Devices) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 23: Global: Neurostimulation Devices (Transcutaneous Electrical Nerve Stimulation Devices) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 24: Global: Neurostimulation Devices (Transcutaneous Electrical Nerve Stimulation Devices) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 25: Global: Neurostimulation Devices (Transcranial Magnetic Stimulation Devices) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 26: Global: Neurostimulation Devices (Transcranial Magnetic Stimulation Devices) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 27: Global: Neurostimulation Devices (Other Devices) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 28: Global: Neurostimulation Devices (Other Devices) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 29: Global: Neurostimulation Devices (Pain Management) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 30: Global: Neurostimulation Devices (Pain Management) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 31: Global: Neurostimulation Devices (Epilepsy) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 32: Global: Neurostimulation Devices (Epilepsy) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 33: Global: Neurostimulation Devices (Essential Tremors) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 34: Global: Neurostimulation Devices (Essential Tremors) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 35: Global: Neurostimulation Devices (Urinary and Fecal Incontinence) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 36: Global: Neurostimulation Devices (Urinary and Fecal Incontinence) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 37: Global: Neurostimulation Devices (Depression) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 38: Global: Neurostimulation Devices (Depression) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 39: Global: Neurostimulation Devices (Dystonia) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 40: Global: Neurostimulation Devices (Dystonia) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 41: Global: Neurostimulation Devices (Parkinson's Disease) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 42: Global: Neurostimulation Devices (Parkinson's Disease) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 43: Global: Neurostimulation Devices (Other Applications) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 44: Global: Neurostimulation Devices (Other Applications) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 45: Global: Neurostimulation Devices (Rehabilitation Centers) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 46: Global: Neurostimulation Devices (Rehabilitation Centers) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 47: Global: Neurostimulation Devices (Hospitals) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 48: Global: Neurostimulation Devices (Hospitals) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 49: Global: Neurostimulation Devices (Medical Clinics) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 50: Global: Neurostimulation Devices (Medical Clinics) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 51: Global: Neurostimulation Devices (Others) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 52: Global: Neurostimulation Devices (Others) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 53: North America: Neurostimulation Devices Market: Sales Value (in Million US$), 2018 & 2023
- Figure 54: North America: Neurostimulation Devices Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 55: United States: Neurostimulation Devices Market: Sales Value (in Million US$), 2018 & 2023
- Figure 56: United States: Neurostimulation Devices Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 57: Canada: Neurostimulation Devices Market: Sales Value (in Million US$), 2018 & 2023
- Figure 58: Canada: Neurostimulation Devices Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 59: Europe: Neurostimulation Devices Market: Sales Value (in Million US$), 2018 & 2023
- Figure 60: Europe: Neurostimulation Devices Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 61: Germany: Neurostimulation Devices Market: Sales Value (in Million US$), 2018 & 2023
- Figure 62: Germany: Neurostimulation Devices Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 63: France: Neurostimulation Devices Market: Sales Value (in Million US$), 2018 & 2023
- Figure 64: France: Neurostimulation Devices Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 65: United Kingdom: Neurostimulation Devices Market: Sales Value (in Million US$), 2018 & 2023
- Figure 66: United Kingdom: Neurostimulation Devices Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 67: Italy: Neurostimulation Devices Market: Sales Value (in Million US$), 2018 & 2023
- Figure 68: Italy: Neurostimulation Devices Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 69: Spain: Neurostimulation Devices Market: Sales Value (in Million US$), 2018 & 2023
- Figure 70: Spain: Neurostimulation Devices Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 71: Russia: Neurostimulation Devices Market: Sales Value (in Million US$), 2018 & 2023
- Figure 72: Russia: Neurostimulation Devices Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 73: Others: Neurostimulation Devices Market: Sales Value (in Million US$), 2018 & 2023
- Figure 74: Others: Neurostimulation Devices Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 75: Asia Pacific: Neurostimulation Devices Market: Sales Value (in Million US$), 2018 & 2023
- Figure 76: Asia Pacific: Neurostimulation Devices Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 77: China: Neurostimulation Devices Market: Sales Value (in Million US$), 2018 & 2023
- Figure 78: China: Neurostimulation Devices Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 79: Japan: Neurostimulation Devices Market: Sales Value (in Million US$), 2018 & 2023
- Figure 80: Japan: Neurostimulation Devices Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 81: India: Neurostimulation Devices Market: Sales Value (in Million US$), 2018 & 2023
- Figure 82: India: Neurostimulation Devices Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 83: South Korea: Neurostimulation Devices Market: Sales Value (in Million US$), 2018 & 2023
- Figure 84: South Korea: Neurostimulation Devices Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 85: Australia: Neurostimulation Devices Market: Sales Value (in Million US$), 2018 & 2023
- Figure 86: Australia: Neurostimulation Devices Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 87: Indonesia: Neurostimulation Devices Market: Sales Value (in Million US$), 2018 & 2023
- Figure 88: Indonesia: Neurostimulation Devices Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 89: Others: Neurostimulation Devices Market: Sales Value (in Million US$), 2018 & 2023
- Figure 90: Others: Neurostimulation Devices Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 91: Latin America: Neurostimulation Devices Market: Sales Value (in Million US$), 2018 & 2023
- Figure 92: Latin America: Neurostimulation Devices Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 93: Brazil: Neurostimulation Devices Market: Sales Value (in Million US$), 2018 & 2023
- Figure 94: Brazil: Neurostimulation Devices Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 95: Mexico: Neurostimulation Devices Market: Sales Value (in Million US$), 2018 & 2023
- Figure 96: Mexico: Neurostimulation Devices Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 97: Others: Neurostimulation Devices Market: Sales Value (in Million US$), 2018 & 2023
- Figure 98: Others: Neurostimulation Devices Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 99: Middle East and Africa: Neurostimulation Devices Market: Sales Value (in Million US$), 2018 & 2023
- Figure 100: Middle East and Africa: Neurostimulation Devices Market: Breakup by Country (in %), 2023
- Figure 101: Middle East and Africa: Neurostimulation Devices Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 102: Global: Neurostimulation Devices Industry: SWOT Analysis
- Figure 103: Global: Neurostimulation Devices Industry: Value Chain Analysis
- Figure 104: Global: Neurostimulation Devices Industry: Porter's Five Forces Analysis
List of Tables
- Table 1: Global: Neurostimulation Devices Market: Key Industry Highlights, 2023 and 2032
- Table 2: Global: Neurostimulation Devices Market Forecast: Breakup by Stimulation Type (in Million US$), 2024-2032
- Table 3: Global: Neurostimulation Devices Market Forecast: Breakup by Device Type (in Million US$), 2024-2032
- Table 4: Global: Neurostimulation Devices Market Forecast: Breakup by Application (in Million US$), 2024-2032
- Table 5: Global: Neurostimulation Devices Market Forecast: Breakup by End-User (in Million US$), 2024-2032
- Table 6: Global: Neurostimulation Devices Market Forecast: Breakup by Region (in Million US$), 2024-2032
- Table 7: Global: Neurostimulation Devices Market: Competitive Structure
- Table 8: Global: Neurostimulation Devices Market: Key Players
The global neurostimulation devices market size reached US$ 8.7 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 20.6 Billion by 2032, exhibiting a growth rate (CAGR) of 9.7% during 2024-2032. The growing aging population coupled with the rising healthcare expenditure, development of non-invasive or minimally invasive neurostimulation technologies, and improved reimbursement policies by government and private health insurers are some of the major factors propelling the market.
Neurostimulation devices are advanced medical technologies designed to modulate and influence neural activity within the human body. These devices work by delivering electrical or magnetic impulses to specific regions of the nervous system, aiming to alleviate various neurological conditions and chronic disorders. They offer a promising non-invasive or minimally invasive therapeutic approach, enhancing the quality of life for patients and potentially opening up new avenues for treating various neurological disorders. The two primary types of neurostimulation devices are deep brain stimulation and spinal cord stimulation. DBS involves implanting electrodes into targeted brain areas to regulate abnormal neural signals and treat conditions such as Parkinson's disease, essential tremor, and dystonia.
The growing aging population is driving the global market. As the elderly population grows, the demand for neurostimulation devices to manage these conditions is likely to rise. Moreover, the development of non-invasive or minimally invasive neurostimulation technologies has expanded the potential patient pool, as these options often offer reduced risks and quicker recovery times compared to traditional surgical procedures. Besides, improved reimbursement policies by government and private health insurers in some regions have made neurostimulation treatments more accessible to patients, encouraging market growth. Also, ongoing research and clinical trials have provided additional evidence for the safety and efficacy of neurostimulation devices. Positive results from these studies have increased confidence in the technology among medical professionals and patients. Furthermore, the rising healthcare expenditure is supporting the growth of market solutions as neurostimulation devices offer a cost-effective approach to managing chronic conditions, which has driven their adoption.
Neurostimulation Devices Market Trends/Drivers:
Increasing Prevalence of Neurological Disorders
Neurological conditions such as Parkinson's disease, epilepsy, chronic pain, and depression affect millions of people worldwide, leading to significant healthcare burdens. Neurostimulation devices offer a promising solution for patients who are refractory to conventional treatments or experience severe side effects. Deep brain stimulation (DBS) has demonstrated remarkable efficacy in managing movement disorders, such as Parkinson's disease, thereby augmenting the demand for these devices. Additionally, the escalating incidence of chronic pain, particularly due to aging populations and sedentary lifestyles, fuels the need for spinal cord stimulation (SCS) devices to provide pain relief without relying heavily on medications. As governments and healthcare organizations prioritize improved patient outcomes and seek innovative solutions, the demand for neurostimulation devices is expected to grow steadily.
Continual Advancements in Neurostimulation Technologies
Continuous research and development efforts have led to the creation of more sophisticated and targeted neurostimulation devices. Innovations include smaller and more precise electrodes, improved battery life, and the integration of closed-loop systems that can automatically adjust stimulation parameters based on real-time patient needs. These advancements translate to enhanced treatment outcomes, reduced side effects, and increased patient comfort. Moreover, the development of minimally invasive procedures for implanting neurostimulation devices has expanded their applicability to a broader patient population, making the treatments more accessible and appealing to both patients and healthcare providers. As technology continues to evolve, neurostimulation devices will likely become even more efficient and adaptable, further impelling their adoption and market penetration.
Growing Awareness and Acceptance of Neuromodulation Therapies
As more clinical evidence supports the effectiveness of neurostimulation devices in treating various neurological disorders, medical practitioners increasingly recommend these therapies to their patients. Additionally, patient advocacy groups and awareness campaigns have played a crucial role in educating individuals about the potential benefits of neurostimulation, leading to greater patient acceptance of these treatments. The success stories of patients who have experienced significant improvements in their quality of life through neurostimulation devices have further contributed to the positive perception of these therapies. As trust in neuromodulation grows, the demand for these devices is expected to increase, fuelling the market expansion. Furthermore, collaborations between healthcare organizations, researchers, and device manufacturers to spread awareness and ensure appropriate usage will contribute to the sustained growth of the neurostimulation devices market.
Neurostimulation Devices Industry Segmentation:
IMARC Group provides an analysis of the key trends in each segment of the global neurostimulation devices market report, along with forecasts at the global, regional and country levels from 2024-2032. Our report has categorized the market based on stimulation type, device type, application, and end-user.
Breakup by Stimulation Type:
Internal Stimulation
External Stimulation
The report has provided a detailed breakup and analysis of the market based on the stimulation type. This includes internal stimulation and external stimulation.
Internal stimulation devices form a significant segment within the neurostimulation market, characterized by their implantable nature. These devices are surgically placed within the body to deliver targeted electrical or magnetic stimulation directly to specific neural structures. The demand for internal stimulation devices is driven by their efficacy in managing complex neurological disorders that do not respond adequately to medications or other treatments. The ability to precisely target neural circuits while providing reversible and adjustable stimulation parameters enhances treatment outcomes, leading to improved patient quality of life.
On the other hand, external stimulation devices represent another substantial segment in the neurostimulation market, characterized by their non-invasive or minimally invasive nature. These devices are applied externally to the body's surface, delivering stimulation without the need for surgical implantation.
Breakup by Device Type:
SCS (Spinal Cord Stimulation) Devices
DBS (Deep Brain Stimulation) Devices
SNS (Sacral Nerve Stimulation) Devices
VNS (Vagus Nerve Stimulation) Devices
GES (Gastric Electrical Stimulation) Devices
Transcutaneous Electrical Nerve Stimulation Devices
Transcranial Magnetic Stimulation Devices
Others
SCS (spinal cord stimulation) dominates the market
The report has provided a detailed breakup and analysis of the market based on the device type. This includes spinal cord stimulation (SCS) devices, deep brain stimulation (DBS) devices, sacral nerve stimulation (SNS) devices, vagus nerve stimulation (VNS) devices, gastric electrical stimulation (GES) devices, transcutaneous electrical nerve stimulation devices, transcranial magnetic stimulation devices, and other. According to the report, SCS (spinal cord stimulation) devices represented the largest segment.
SCS involves the implantation of electrodes along the spinal cord, where electrical impulses are delivered to modulate pain signals and provide relief for chronic pain conditions. The minimally invasive nature of the procedure offers numerous benefits, including shorter recovery times and reduced risks compared to invasive surgeries. Additionally, the customizable nature of SCS allows for individualized programming to target specific pain areas, tailoring treatment to meet each patient's unique needs. Moreover, continual advancements in SCS technology have led to more sophisticated devices with improved battery life, smaller implants, and enhanced programming capabilities, providing greater patient comfort and long-term sustainability. The focus on patient-centered care and shared decision-making has led to an increased emphasis on personalized pain management plans. Spinal cord stimulation, with its individualized programming capabilities, aligns well with this patient-centric approach, fueling its adoption in pain management strategies.
Breakup by Application:
Pain Management
Epilepsy
Essential Tremors
Urinary and Fecal Incontinence
Depression
Dystonia
Parkinson's Disease
Others
Pain management dominates the market
The report has provided a detailed breakup and analysis of the market based on the application. This includes pain management, epilepsy, essential tremors, urinary and fecal incontinence, depression, dystonia, Parkinson's disease, and others. According to the report, pain management represents the largest segment.
Neurostimulation devices designed for pain management offer a promising alternative, particularly spinal cord stimulation (SCS) and peripheral nerve stimulation (PNS). These technologies work by delivering controlled electrical impulses to target nerves, modulating pain signals, and thereby reducing the perception of pain. Pain management through neurostimulation has demonstrated remarkable efficacy in various chronic pain conditions, including neuropathic pain, failed back surgery syndrome (FBSS), and complex regional pain syndrome (CRPS). Additionally, the advancements in neurostimulation technology have led to more personalized and precise pain management solutions, allowing for tailored treatment strategies based on individual patient needs.
Breakup by End-User:
Rehabilitation Centers
Hospitals
Medical Clinics
Others
Hospitals dominates the market
A detailed breakup and analysis of the market based on the end user has also been provided in the report. This includes rehabilitation centers, hospitals, medical clinics, and others. According to the report, hospitals represented the largest segment.
Hospitals play a central role in the diagnosis, treatment, and management of various neurological and chronic disorders, which often require neurostimulation therapies as part of the treatment plan. Hospitals have access to multidisciplinary teams of medical professionals, including neurologists, neurosurgeons, pain specialists, and anesthesiologists, who collaborate to provide comprehensive care to patients requiring neurostimulation therapies. Additionally, they are equipped with state-of-the-art operating rooms and facilities that meet stringent regulatory standards, ensuring safe and effective implantation procedures. Furthermore, neurostimulation devices often require careful programming and adjustments to optimize treatment outcomes, and hospitals have the resources to support these ongoing patient management needs.
Breakup by Region:
North America
United States
Canada
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
North America exhibits a clear dominance, accounting for the largest neurostimulation devices market share.
The report has also provided a comprehensive analysis of all the major regional markets, which includes North America (the United States and Canada), Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and Others), Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and Others), Latin America (Brazil, Mexico, and Others), and the Middle East and Africa. According to the report, North America accounted for the largest market share.
North America has a well-established healthcare infrastructure and is at the forefront of medical research and technological advancements. The presence of leading healthcare facilities, specialized neurology centers, and renowned research institutions fosters innovation and the adoption of cutting-edge neurostimulation technologies. Moreover, the region has a high prevalence of neurological disorders and chronic pain conditions, leading to a substantial demand for neurostimulation devices for effective management and treatment. The region's aging population, coupled with a growing awareness of neurostimulation therapies among patients and healthcare providers, further fuels market growth. Additionally, favorable reimbursement policies and regulatory frameworks in North America support the widespread adoption of neurostimulation devices.
Competitive Landscape:
Neurostimulation device manufacturers are heavily investing in research and development to enhance their existing products and develop new, innovative technologies. This involves conducting clinical trials, exploring new applications for neurostimulation, and improving the safety and efficacy of their devices. Moreover, companies are introducing new neurostimulation devices or release upgraded versions of existing ones. These launches aim to provide patients and healthcare professionals with state-of-the-art solutions that offer better outcomes and user experiences. Furthermore, companies actively seek to expand their market presence, both geographically and in terms of applications. They may pursue regulatory approvals in different regions, explore new therapeutic areas for neurostimulation, or target specific patient populations with unmet needs. Also, collaboration with other companies, research institutions, and healthcare organizations is common in the neurostimulation devices market.
The report has provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:
Biocontrol Medical
Boston Scientific Corporation
Cyberonics Inc.
Medtronic Inc.
Neuronetics Inc.
Neuropace Inc.
Neurosigma Inc.
Nevro Corporation
ST. Jude Medical Inc.
Synapse Biomedical Inc.
Recent Developments:
In April 2023, Synapse Biomedical Inc. received the approval for diaphragm pacing system, NeuRx DPS(R). The NeuRx DPS(R) is a battery-powered device that delivers electrical stimulation via four percutaneous intramuscular electrodes implanted into the diaphragm with minimally invasive laparoscopy. It is intended for use in patients with stable SCI with stimulatable diaphragms, but who lack control of their diaphragms. The device is indicated to allow patients 18 years and older to breathe without the assistance of a mechanical ventilator for at least four continuous hours a day.
In March 2023, Nevro Corporation announced the Launch of Revolutionary HFX iQ(TM) Spinal Cord Stimulation System to Personalize Treatment of Chronic Pain. It combines clinical inputs, such as pain relief and pain score, along with quality of life inputs, such as pain medication and activity level changes, to provide an individualized program setting for each patient.
In September 2022, Neuronetics Inc. launched Innovations to NeuroStar(R) Advanced Therapy's Proprietary TrakStar(R) Platform. The TrakStar upgrades include a simplified interface to quickly sort and prioritize potential patients with ease. It also streamlines the patient journey by bridging our proprietary PHQ-10 platform with our HIPAA-compliant TrakStar patient data management system making it easier to identify new patients and those needing re-treatment.
Key Questions Answered in This Report
- 1. What was the size of the global neurostimulation devices market in 2023?
- 2. What is the expected growth rate of the global neurostimulation devices market during 2024-2032?
- 3. What are the key factors driving the global neurostimulation devices market?
- 4. What has been the impact of COVID-19 on the global neurostimulation devices market?
- 5. What is the breakup of the global neurostimulation devices market based on the device type?
- 6. What is the breakup of the global neurostimulation devices market based on the application?
- 7. What is the breakup of the global neurostimulation devices market based on the end-user?
- 8. What are the key regions in the global neurostimulation devices market?
- 9. Who are the key players/companies in the global neurostimulation devices market?
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
5 Global Neurostimulation Devices Market
- 5.1 Market Overview
- 5.2 Market Performance
- 5.3 Impact of COVID-19
- 5.4 Market Forecast
6 Market Breakup by Stimulation Type
- 6.1 Internal Stimulation
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
- 6.2 External Stimulation
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
7 Market Breakup by Device Type
- 7.1 SCS (Spinal Cord Stimulation) Devices
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
- 7.2 DBS (Deep Brain Stimulation) Devices
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
- 7.3 SNS (Sacral Nerve Stimulation) Devices
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
- 7.4 VNS (Vagus Nerve Stimulation) Devices
- 7.4.1 Market Trends
- 7.4.2 Market Forecast
- 7.5 GES (Gastric Electrical Stimulation) Devices
- 7.5.1 Market Trends
- 7.5.2 Market Forecast
- 7.6 Transcutaneous Electrical Nerve Stimulation Devices
- 7.6.1 Market Trends
- 7.6.2 Market Forecast
- 7.7 Transcranial Magnetic Stimulation Devices
- 7.7.1 Market Trends
- 7.7.2 Market Forecast
- 7.8 Others
- 7.8.1 Market Trends
- 7.8.2 Market Forecast
8 Market Breakup by Application
- 8.1 Pain Management
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
- 8.2 Epilepsy
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
- 8.3 Essential Tremors
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
- 8.4 Urinary and Fecal Incontinence
- 8.4.1 Market Trends
- 8.4.2 Market Forecast
- 8.5 Depression
- 8.5.1 Market Trends
- 8.5.2 Market Forecast
- 8.6 Dystonia
- 8.6.1 Market Trends
- 8.6.2 Market Forecast
- 8.7 Parkinson's Disease
- 8.7.1 Market Trends
- 8.7.2 Market Forecast
- 8.8 Others
- 8.8.1 Market Trends
- 8.8.2 Market Forecast
9 Market Breakup by End-User
- 9.1 Rehabilitation Centers
- 9.1.1 Market Trends
- 9.1.2 Market Forecast
- 9.2 Hospitals
- 9.2.1 Market Trends
- 9.2.2 Market Forecast
- 9.3 Medical Clinics
- 9.3.1 Market Trends
- 9.3.2 Market Forecast
- 9.4 Others
- 9.4.1 Market Trends
- 9.4.2 Market Forecast
10 Market Breakup by Region
- 10.1 North America
- 10.1.1 United States
- 10.1.1.1 Market Trends
- 10.1.1.2 Market Forecast
- 10.1.2 Canada
- 10.1.2.1 Market Trends
- 10.1.2.2 Market Forecast
- 10.1.1 United States
- 10.2 Europe
- 10.2.1 Germany
- 10.2.1.1 Market Trends
- 10.2.1.2 Market Forecast
- 10.2.2 France
- 10.2.2.1 Market Trends
- 10.2.2.2 Market Forecast
- 10.2.3 United Kingdom
- 10.2.3.1 Market Trends
- 10.2.3.2 Market Forecast
- 10.2.4 Italy
- 10.2.4.1 Market Trends
- 10.2.4.2 Market Forecast
- 10.2.5 Spain
- 10.2.5.1 Market Trends
- 10.2.5.2 Market Forecast
- 10.2.6 Russia
- 10.2.6.1 Market Trends
- 10.2.6.2 Market Forecast
- 10.2.7 Others
- 10.2.7.1 Market Trends
- 10.2.7.2 Market Forecast
- 10.2.1 Germany
- 10.3 Asia Pacific
- 10.3.1 China
- 10.3.1.1 Market Trends
- 10.3.1.2 Market Forecast
- 10.3.2 Japan
- 10.3.2.1 Market Trends
- 10.3.2.2 Market Forecast
- 10.3.3 India
- 10.3.3.1 Market Trends
- 10.3.3.2 Market Forecast
- 10.3.4 South Korea
- 10.3.4.1 Market Trends
- 10.3.4.2 Market Forecast
- 10.3.5 Australia
- 10.3.5.1 Market Trends
- 10.3.5.2 Market Forecast
- 10.3.6 Indonesia
- 10.3.6.1 Market Trends
- 10.3.6.2 Market Forecast
- 10.3.7 Others
- 10.3.7.1 Market Trends
- 10.3.7.2 Market Forecast
- 10.3.1 China
- 10.4 Latin America
- 10.4.1 Brazil
- 10.4.1.1 Market Trends
- 10.4.1.2 Market Forecast
- 10.4.2 Mexico
- 10.4.2.1 Market Trends
- 10.4.2.2 Market Forecast
- 10.4.3 Others
- 10.4.3.1 Market Trends
- 10.4.3.2 Market Forecast
- 10.4.1 Brazil
- 10.5 Middle East and Africa
- 10.5.1 Market Trends
- 10.5.2 Market Breakup by Country
- 10.5.3 Market Forecast
11 SWOT Analysis
- 11.1 Overview
- 11.2 Strengths
- 11.3 Weaknesses
- 11.4 Opportunities
- 11.5 Threats
12 Value Chain Analysis
- 12.1 Overview
- 12.2 Inbound Logistics
- 12.3 Operations
- 12.4 Outbound Logistics
- 12.5 Marketing and Sales
- 12.6 Post Sales Services
13 Porters Five Forces Analysis
- 13.1 Overview
- 13.2 Bargaining Power of Buyers
- 13.3 Bargaining Power of Suppliers
- 13.4 Degree of Competition
- 13.5 Threat of New Entrants
- 13.6 Threat of Substitutes
14 Price Indicators
15 Competitive Landscape
- 15.1 Market Structure
- 15.2 Key Players
- 15.3 Profiles of Key Players
- 15.3.1 Biocontrol Medical
- 15.3.1.1 Company Overview
- 15.3.1.2 Product Portfolio
- 15.3.2 Boston Scientific Corporation
- 15.3.2.1 Company Overview
- 15.3.2.2 Product Portfolio
- 15.3.2.3 Financials
- 15.3.2.4 SWOT Analysis
- 15.3.3 Cyberonics Inc.
- 15.3.3.1 Company Overview
- 15.3.3.2 Product Portfolio
- 15.3.4 Medtronic Inc.
- 15.3.4.1 Company Overview
- 15.3.4.2 Product Portfolio
- 15.3.5 Neuronetics Inc.
- 15.3.5.1 Company Overview
- 15.3.5.2 Product Portfolio
- 15.3.5.3 Financials
- 15.3.6 Neuropace Inc.
- 15.3.6.1 Company Overview
- 15.3.6.2 Product Portfolio
- 15.3.7 Neurosigma Inc.
- 15.3.7.1 Company Overview
- 15.3.7.2 Product Portfolio
- 15.3.8 Nevro Corporation
- 15.3.8.1 Company Overview
- 15.3.8.2 Product Portfolio
- 15.3.8.3 Financials
- 15.3.9 ST. Jude Medical Inc.
- 15.3.9.1 Company Overview
- 15.3.9.2 Product Portfolio
- 15.3.10 Synapse Biomedical Inc.
- 15.3.10.1 Company Overview
- 15.3.10.2 Product Portfolio
- 15.3.1 Biocontrol Medical
